Warren Buffett has a surprising advice for eToro's CEO
Often referred to as the "Oracle of Omaha,' Buffett's sage advice is paid heed to by the younger generations of CEOs as well.
Yoni Assia, founder and CEO of the Israel-based trading and investment firm eToro (Nasdaq: ETOR), recently revealed that it was Berkshire Hathaway founder who "actually convinced" him to focus more on stocks and less on crypto.
Assia made the revelation while speaking on CNBC's 'Squawk Box' on May 15, a day after eToro made its Nasdaq debut.
Buffett's dislike of crypto is public knowledge, as he once referred to Bitcoin as 'probably rat poison squared' and another time called it a 'gambling token.' Understandably, Berkshire Hathaway has never invested in crypto.
During the interview, the eToro CEO said that the firm was very early to crypto. In fact, it was the first regulated company in Europe to launch crypto trading, he said.
Assia also reflected on the decision to pull back from the plan to go public in 2011 and said it was a lesson, as he learned that it was important for a company to become profitable before going public. It was therefore the right decision to wait longer in order to become profitable to go public now, he added.
"Nobody doubts that crypto is here to stay," Assia underlined. He further claimed that while crypto accounted for 25% of the company's revenue last year, stocks accounted for 75% of the revenue.
ETOR made its Nasdaq debut on May 14 with the IPO price of $52 a share but opened at $69.69 before surging to $74.28.
The stock was trading at $64.40 at the time of writing, down 3.83% since the last day's close.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Jefferies Lowers Monday.com (MNDY) PT to $330, Cites Revenue Raise, AI Fears
Ltd. (NASDAQ:MNDY) is one of the best upside stocks to invest in now. On August 12, Jefferies analyst Brent Thill lowered the firm's price target on to $330 from $360, while keeping a Buy rating on the shares. Although the company's Q2 2025 results were robust, the analyst's sentiment was driven by the small FY25 revenue raise and AI fears. reported a strong 27% year-over-year revenue increase in Q2, which reached $299 million. The company's non-GAAP operating income also grew to $45.1 million, up from $38.4 million in the same quarter of the previous year. Additionally, net cash from operating activities increased to $66.8 million from $55.8 million year-over-year. Software engineers collaborating on a project while seated in a shared workspace. Monday CRM product reached $100 million in Annual Recurring Revenue/ARR within 3 years of its launch. The company also introduced new AI-powered features, including Monday Magic, Monday Vibe, and Monday Sidekick. For Q3, expects total revenue to be between $311 and $313 million, with a non-GAAP operating income projected to be between $34 and $36 million. Ltd. (NASDAQ:MNDY) develops software applications internationally. The company provides Work Operating System/OS, which is a cloud-based visual work OS that consists of modular building blocks used and assembled to create software applications and work management tools. While we acknowledge the potential of MNDY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
27 minutes ago
- Yahoo
Susquehanna Raises eBay (EBAY) Pt to $95, Cites Q2 Strength
eBay Inc. (NASDAQ:EBAY) is one of the best performing S&P 500 stocks to buy now. Susquehanna analyst Shyam Patil raised the firm's price target on eBay to $95 from $70 and kept a Neutral rating on the shares. This decision followed the company's Q2 2025 earnings report, which was driven by strength in the US and solid GMV (Gross Merchandise Volume) growth acceleration in its focus categories. eBay reported revenue of $2.7 billion, which was an increase of 6% on an as-reported basis and 4% on an FX-neutral basis compared to the previous year. GMV was $19.5 billion, also up 6% as reported and 4% on an FX-neutral basis. The company's total advertising offerings generated $482 million in revenue, accounting for 2.5% of GMV. A close-up view of a customers phone, using the mobile app to buy products. For Q3, eBay is providing guidance that projects revenue between $2.69 and $2.74 billion, and GMV in the range of $19.2 to $19.6 billion. The company expects FX-neutral year-over-year growth for both revenue and GMV to be between 3% and 5%. eBay Inc. (NASDAQ:EBAY) operates marketplace platforms that connect buyers and sellers in the US, the UK, China, Germany, and internationally. While we acknowledge the potential of EBAY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
27 minutes ago
- Yahoo
Piper Sandler Raises IDEXX Laboratories (IDXX) PT to $700, Cites Strong Q2 Results
IDEXX Laboratories Inc. (NASDAQ:IDXX) is one of the best performing S&P 500 stocks to buy now. On August 11, Piper Sandler raised the firm's price target on Idexx Laboratories to $700 from $510 following the company's Q2 2025 financial results. The firm kept a Neutral rating on the shares. IDEXX Laboratories reported total revenues of $1,109 million in Q2, which was an increase of 11% as reported and 9% organically, compared to the prior year. This was driven by a strong performance from its Companion Animal Group/CAG and Water segments, which saw revenue increases of 11% and 9% as reported, respectively. A veterinarian in a veterinary clinic examining a companion animal. Within the Companion Animal Group, IDEXX VetLab consumables revenue grew by 15% as reported and 14% organically. The company also saw a 66% reported increase in CAG Diagnostics capital instrument revenues, driven by record placements of its new IDEXX InVue Dx instrument. Rapid assay products revenues, however, declined by 3% as both reported and organic, as some testing shifted to new modalities. IDEXX Laboratories Inc. (NASDAQ:IDXX) develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the US and internationally. While we acknowledge the potential of IDXX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
